cysteine has been researched along with Coronary Restenosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Celejewska-Wójcik, N; Jawien, J; Maga, M; Maga, P; Rewerska, B; Rewerski, P; Sanak, M; Szczeklik, W; Wachsmann, A | 1 |
Fan, QX; Geng, JG; Wang, JT; Wang, YJ | 1 |
2 other study(ies) available for cysteine and Coronary Restenosis
Article | Year |
---|---|
Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease.
Topics: Aged; Angioplasty; Arterial Occlusive Diseases; Biomarkers; Coronary Restenosis; Cysteine; Female; Follow-Up Studies; Humans; Ischemia; Leukotriene E4; Leukotrienes; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Time Factors | 2016 |
Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Coronary Restenosis; Coronary Vessels; Cysteine; Disease Models, Animal; Diterpenes; E-Selectin; Gene Deletion; Humans; Hyperplasia; Inflammation; Macrophages; Mice; Mice, Knockout; NF-kappa B p50 Subunit; Thromboplastin; Tunica Intima; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2007 |